FDA launching medical policy council

Janet Woodcock, director of FDA's Center for Drug Evaluation and Research, announced the creation of the Medical Policy Council as a subsidiary of the CDER executive committee. In an email to CDER staff, Woodcock said the council membership and procedures are being discussed and developed. The council will also consider the best mechanism for involving outside stakeholders, such as establishing a docket for submission of suggested topics (see BioCentury Extra, Jan. 6). ...